Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Minoxidil prevents serotonin loss from MDMA by affecting potassium channels and increasing Akt phosphorylation.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

In 2024, the FDA approved 50 new drugs, including treatments for hair loss, anemia, high blood pressure, and Alzheimer's.

Early minipulse corticosteroid therapy can effectively treat scalp discoid lupus in children.

Early changes in brain chemicals affect how a drug reduces alcohol intake in rats.

Some minoxidil combinations can help differentiate leukemia cells without harming other cells.

Radiesse is a versatile facial injectable used for cosmetic improvements and long-term collagen production, with careful dosing needed to prevent complications.

Three reliable methods were developed to measure Finasteride and Tamsulosin Hydrochloride in medicines.

ADEM is a sudden brain disorder often following infection or vaccination, diagnosed by ruling out other conditions.

Finasteride may cause sexual and psychological side effects by affecting an enzyme related to epinephrine.

The new dutasteride formula can be applied to the skin, may promote hair growth, and has fewer side effects.

Aggressive treatment in young patients with certain drug reactions may lead to multiple autoimmune diseases later.

Pranlukast and mirabegron may work as new diabetes drugs.

Dexamethasone mini-pulse therapy is effective for alopecia areata but less effective for those with early onset or hypothyroidism.

PRP and ADSC therapies show promise in improving symptoms of genital lichen sclerosus with minimal side effects.

Red-light therapy may slow myopia progression better than traditional treatments.

Equine Cushing's disease in horses causes hormonal imbalance, leading to symptoms like abnormal hair growth and requires lifelong treatment with pergolide.

Combining laser and corticosteroid is not better than corticosteroid alone for treating frontal fibrosing alopecia.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

The article concludes that dermatologists should prescribe lifestyle drugs carefully and consider mental health treatments for patients with disorders like BDD.

A nutrition program significantly improved a woman's lupus symptoms.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

The conclusion is that a new method can measure caffeine and drugs in hair, finding caffeine abusers have 70 times more caffeine than normal, with a proposed cut-off value for abuse.

Post-Finasteride Syndrome causes lasting sexual, mood, and metabolic issues, needing personalized treatment and better informed consent.

Laser-Assisted Exosome Delivery showed early skin improvement without side effects, but more research is needed.

Valproate sustained-release is effective and generally safe for short-term treatment of new partial epilepsy.

Neonatal allopregnanolone and stress affect behavior differently in adolescence and adulthood.